Salute e Benessere
New US Consensus Report supports Nevisense
" " says Pia Renaudin , CEO of SciBase.
" " said Dr. Darrell Rigel, board-certified dermatologist, Clinical Professor of Dermatology Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, Adjunct Professor, UT Southwestern Medical School, Consultant Dermatologist, Cooper Clinic. Dr. Rigel served as President of the American Academy of Dermatology, the American Academy of Dermatology Association, the American Society for Dermatologic Surgery and the American Dermatological Association, as a Director of the American Board of Dermatology, and is the current Chair of SkinPAC (the American Academy of Dermatology Association's political action committee).
" " said Dr. Gary Goldenberg , board certified dermatologist and dermatopathologist, CEO and founder of Goldenberg Dermatology PC, and Assistant Clinical Professor of Dermatology at the Icahn School of Medicine at Mount Sinai Hospital in New York City .
The article can be found here : https://jddonline.com/articles/advances-in-technology-melanoma-diagnosis-prognosis-an-expert-consensus-panel-S1545961624P8365X/
Pia Renaudin , CEO, tel. +46732069802, e-mail:
pia.renaudin@scibase.com
Carnegie Investment Bank AB (publ)
Phone: +46 (0)73 856 42 65
E-mail: certifiedadviser@carnegie.se
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/scibase/r/new-us-consensus-report-supports-nevisense,c4031688
The following files are available for download:
View original content: https://www.prnewswire.co.uk/news-releases/new-us-consensus-report-supports-nevisense-302235792.html